Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study

ConclusionsMVC as a switch for a PI/r is safe and effective at maintaining virological suppression while having significant lipid benefits over 96 weeks.

Source: HIV Medicine - July 13, 2017 Category: Infectious Diseases Authors: SL Pett, J Amin, A Horban, J Andrade ‐Villanueva, M Losso, N Porteiro, JS Madero, W Belloso, E Tu, D Silk, A Kelleher, R Harrigan, A Clark, W Sugiura, M Wolff, J Gill, J Gatell, A Clarke, K Ruxrungtham, T Prazuck, R Kaiser, I Woolley, J Alberto Arnaiz, Tags: Short Communication Source Type: research